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Abstract
Background: Bladder cancer is the second most common genitourinary cancer and its incidence is rising 15% annually in Indonesia. Smoking is the leading risk factor of bladder cancer and two thirds of men in Indonesia smokes. This study was conducted to describe the characteristics of bladder cancer based on sex, age and histopathology type in  West Java’s Top Referral Hospital, Indonesia. 
Methods: This study was a descriptive study conducted during theperiod of September to November 2015 using 372 histopathological medical records of patients who had primary and secondary bladder cancer at the Pathology Department, Dr. Hasan Sadikin General Hospital Bandung from January 2010 to December 2014. Data were collected using total sampling method based on the characteristics of age, sex histopathology type, and staging of bladder cancer.
Results: Out of the 372 cases, 298 cases were male and 38 cases were female with a male to female ratio 
of 7.8:1. The age group with the highest incidence was the 50–59 years old group. Infiltrating urothelial carcinoma was the most common histopathology type (71.1%) in primary cancers, 66.1% of cases was muscle invasive while 33.9% was non muscle invasive. Staging pT1 had the most number of cases. The most common site of origin for secondary neoplasm was cervix with adenocarcinoma as the most common histopathology type. 
Conclusions: Bladder cancer is more common in male than female and peaks at the sixth decade of life. 
Infiltrating urothelial carcinoma is the most common histopathology type. [AMJ.2017;4(1):94–9]
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IntroductionBladder cancer is the second most common genitourinary cancer and accounts for 3.2% of the total cancer cases worldwide.1 Based on Globocan Data 2012, the incidence of bladder cancer patients in Indonesia for both sexes is 3.2 per 100,000.1 This incidence is increasing 15% per annum in the last decade in Indonesia.2 The mortality rate is 1.7 per 100,000 cases.1 Bladder cancer is three times more common in male than female.3 However, in women, the disease has a higher mortality and presents in a more advanced stage.4 The peak of bladder cancer is in the sixth or seventh decade.3 The most common histopathology 
type is Infiltrating Urothelial Carcinoma.2The most important risk factor for 
bladder cancer is smoking.5 Two thirds of the Indonesian population of male smokes and West Java has the second highest number of smokers in Indonesia.6 Occupation exposure for example azo dyes used in textile industries is also associated with elevated bladder cancer risk. West Java accounts for the highest clothing production in Indonesia. The increasing number of smokers and exposure to occupational carcinogens along with the increasing geriatric population in West Java will increase the incidence of bladder cancer in West Java, in addition increasing the burden of cancer in Indonesia. Based on the factors above and the differences in genetic composition in Indonesians, the objective of the study was to describe the characteristics of patients 
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with bladder cancer based on age, sex and histopathology type at Dr. Hasan Sadikin General Hospital Bandung as West Java’s Top Referral Hospital  from January 2010 to December 2014.
MethodsThis was a descriptive study of all primary and secondary bladder cancer cases from 1st January 2010 to 31st December 2014 (5 Years) that were collected from the Pathology Department at Dr. Hasan Sadikin General Hospital Bandung. This study was carried out during 6 months from July to December 2015 using medical records. The inclusion criteria of the study were histopathological medical records of patients who were diagnosed with bladder cancer comprising the age, sex and histopathology type. Data was excluded if the medical records were not complete or unclear. From 381 cases of bladder cancer during the period, nine cases were excluded. The total sampling method was used to obtain the samples. 
Bladder tumours were classified histopathologically according to the World 
Health Organization (WHO)/International Society of Urological Pathology consensus 
classification 2004 which classified the tumours into urothelial tumours, squamous neoplasms, glandular neoplasms, neuroendocrine tumours, melanocytic tumours, mesenchymal tumours, haematopoietic and lymphoid tumours.7 Pathological staging was specified according to TMN system with the following stages, pT1: invasion of lamina propria, pT2: invasion of muscularis propria, pT3: invasion of perivesical fat and pT4: invasion of surrounding organs.7 The data was presented in frequency distribution. Ethical clearence was given by the Health Research Ethics 
Committee of Dr. Hasan Sadikin General Hospital.
ResultsThe total number of bladder cancer cases recorded at the Department of Anantomical Pathology in Dr. Hasan Sadikin General Hospital Bandung was 372 cases, consisting of 336 cases of primary bladder cancer and 36 cases of secondary bladder cancer.
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Table 1 Frequency of Bladder Cancer Patients Based on Year
Year
Total Malignant Tumor Cases 
in Dr. Hasan Sadikin General 
Hospital
Bladder Cancer %2010 4,695 66 1.412011 3,476 71 2.042012 3,662 57 1.562013 3,468 93 2.712014 3,206 85 2.68Total 18,507 372 2.02
Table 2 Characteristics of Primary Bladder Cancer Patients Based on Age and Sex
Age in years
Sex
Number of cases %
Male Female<40 30 1 31 9.240–49 32 6 38 11.350–59 94 11 105 31.360–69 65 7 72 21.470–79 64 12 76 22.680–89 13 1 14 4.2Total 298 38 336 100.0
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The highest number of cases and frequency recorded was in year 2013, followed by year 2014. The least number of cases was found in year 2012, however the lowest frequency was found in year 2010 (Table 1).The incidence of bladder cancer was higher in men (88.7%) compared to women (11.3%) with the male to female ratio was 7.8:1. For male the highest incidence was found in the age group 50–59 years while in female, the highest incidence was in the age group 50–59 years and 70–79 years. The oldest age reported was 87 years with histopathological 
type infiltrating urothelial carcinoma. The youngest age reported was 9 years old with histopathological type rhabdomyosarcoma (Table 2).The most common histopathology type was urothelial neoplasias, which was divided into invasive (71.1%) and non invasive neoplasias (15.2%). In this study, the invasive urothelial 
neoplasia, infiltrating urothelial carcinoma had the highest percentage of cases. The next most common histopathology type was squamous cell carcinoma which constituted 6.3% of the total cases, followed by adenocarcinoma (5.3%). The least common histopathology type was rhabdomyosarcoma (2.1%) (Table 3).The invasive urothelial carcinoma that invaded the lamina propria, pT1 (66.1%) was the most common staging reported followed by pT4 (22.2%). The least common staging was pT3 (2.09%), that had invaded the perivesical fat. 33.9% of the patients had muscle- invasive disease at the time of the presentation while the remaining 66.1% had non muscle-invasive disease (pT1) (Table 4).There was a total of 36 secondary bladder cancer cases, 63.9% of the cases were female while 36.1% of the cases were male with a male to female ratio of 0.6:1. The most common age group was 40-49 years old. The most common 
Table 3 Characteristics Primary Bladder Cancer Patients Based on Histopathology Type 
	 	According	to	WHO	Classification	2004
Histopathology Type Number of cases %Invasive urothelial neoplasias
      Infiltrating  urothelial carcinoma 239 71.1Non-invasive  urothelial neoplasias      Non invasive papillary urothelial neoplasm of low malignant potential 26 7.7      Non invasive papillary urothelial carcinoma, low grade 20 6.0      Non invasive papillary urothelial carcinoma, high grade 5 1.5Squamous cell carcinom 21 6.3Adenocarcinoma 18 5.3Rhabdomyosarcoma 7 2.1Total 336 100.0
Table	4	Pathologic	Staging	of	Infiltrating	Urothelial	CarcinomaAccording	to	WHO
Classification	2004	Based	on	Sex
Stage
Sex
Total %
Male FemalepT1 141 17 158 66.1pT2 22 1 23 9.6pT3 5 0 5 2.1pT4 51 2 53 22.2Total 219 20 239 100.0
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histopathology type was adenocarcinoma (36.1%). The least common histopathology 
type was rhabdomyosarcoma (2.8%).  Cervix was the most common site of origin for secondary bladder cancer accounting for 52.8% of the cases, followed by prostate (13.9%). The least common site of origin was intra abdomen, vulva and ileum (Table 5).
Discussion In this study, the incidence of bladder cancer was higher in men than women, with the male to female ratio of 7.8:1. This ratio is comparable to previous studies in India3 (8.6:1) and Malaysia8 (9.4:1)  but was higher 
Table 5 Characteristics of Secondary 
  Bladder Cancer
Characteristics Number of cases
Sex     Male 13     Female 23     Male to female ratio  0.6:1Age (years)<40 7   40–49 12   50–59 11   60–69 5   70–79 1   80–89 0Histopathology type   Adenocarcinoma 13   Squamous cell carcinoma 7   Rhadmonyosarcoma 1
   Not specified 15Origin
    Cervix 19    Prostate 5    Ovarian 3
    Colon 3    Rectum 2    Intra abdomen 2    Vulva 1    Ileum   1
than other studies conducted in Surabaya, Indonesia9 and Nepal10 with ratio of 3–4:1. The higher incidence in men may be attributed to the higher exposure to carcinogens as smoking is the leading risk factor of bladder cancer and West Java has the second highest number of smokers aged more than 10 in Indonesia.6 The lower incidence in female may be attributed to the decreased exposure to carcinogens from cigarettes in addition to less occupational exposure as less number of women work outside their homes.The mean age of diagnosis in this study was 58.5 which is similar to other studies in North India11 (59.0) and Indonesia9 (57.8). In this study, 79.5% of the patients were older than 50 years and this was similar as reported in North India11 which was 83.7%. Overall, the highest incidence was in the age group 50–59 years. This is similar to a previous study in Surabaya, Indonesia.9 In male, the highest incidence was in the age group 50–59 years while in female, the incidence peaks at the age group 50–59 years  and 70–79 years. A study in Nepal10 and North India11 showed an older age group for male, 61–70 years as the peak age group, while the peak age group for female were similar, 51–60 years and 71–80 years.10 The lower peak incidence age group of men in Indonesia is linked to the higher number of smokers who start smoking at a younger age of 10 years which increases the exposure of carcinogens at an earlier age.
Infiltrating urothelial carcinoma was the most common histopathology type in this study. This is coherent with other studies 
which reported similar findings of infiltrating urothelial carcinoma being the most common type, however the percentage in this study was much lower than reported in other studies.3,8,10,11 Squamous cell carcinoma prevalence varies in different parts of the world and is higher in Egypt8 where schistosomiasis is endemic. In this study the prevalence was 5.4% which is comparable to the study in Nepal10 but was much higher than reported in the study conducted in Malaysia8 (1.2%) and North India11 (2.5%). The histopathology type adenocarcinoma was accounted for 5.6% of the total cases and is similar to the study in Malaysia8(6.0%) but studies in Nepal12 and India3 showed a lower percentage of 0.93% and 1.25%respectively. Numerous studies have been published to show the survival rate differences between invasive and non-invasive tumours. In this study, the urothelial tumors which were invasive was 82.4% while the non-invasive 
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urothelial tumours was 17.6%. The percentage of non-invasive tumours reported is much lower than the previous study conducted in Malaysia.8In terms of age, young people tend to develop more non-invasive urothelial tumours rather invasive urothelial tumours and this is the characteristic of bladder cancer that differentiates it from other cancers where younger people develop more aggressive forms of the disease. However in this study, there was a higher percentage of invasive urothelial tumours in young people compared to non-invasive tumours. This is different from the studies in Taipei13 and Greece14 where there are more non-invasive tumours than invasive tumours at time of presentation in younger people. In this study, 33.9% of the patients had muscle-invasive disease at the time of the presentation while the remaining 66.1% had non muscle-invasive disease. This is different from other previous studies where there is a higher percentage of  muscle invasive rather than non muscle-invasive disease.10 In this study, women had less invasive and less aggressive form of the disease and is thus similar to  a  previous study in Austria.15 This is opposing to other previous studies conducted in India and Nepal which stated that women have more invasive and more aggressive form of disease at time of diagnosis.3,10,12The less aggressive and less invasive form of bladder cancer in women as reported in this study, attributed to the prompt diagnosis by clinicians when presenting symptoms occurred.
Secondary cancers that invade or infiltrate the bladder are very rare. In this study, there were only 36 cases reported in the period of 5 years and accounts for 9.7% of the total bladder cancer cases. In a previous study, it was reported that secondary bladder neoplasm represents 2% of the total malignant bladder neoplasm.16 The percentage of secondary tumours in this current study was much higher than the previous study. The most common histopathology type of secondary bladder cancers reported was adenocarcinoma (36.1%). Since adenocarcinomas are rare in primary bladder neoplasm, when an adenocarcinoma histopathology type is found, the pathologist should carry out further investigation of possible metastasis of other origin as the presence of adenocarcinomas was high in secondary neoplasms in this study. Some tumors of histopathology type were not 
specified, because more immunohistochemical workup is needed to identify the tumours 
that are present with less histological characteristics.7  In this study, the most common sites of origin in secondary bladder neoplasms were the cervix in female and prostat in male. In previous studies, the most common site of origin is from colonic carcinomas, prostate, rectum and uterine cervix .7,17From this study, it can be concluded that bladder cancer is more common in male than female. Bladder cancer peaks at the 6th decade for male while in female, it peaks at the 6th and 8th decade. Infiltrating urothelial carcinoma is the most common histopathology type overall while rhabdomyosarcoma is the most uncommon histopathology type in primary bladder cancers. There are more non muscles invasive tumours (stage pT1) present. The most common site of metastasis to the bladder is the cervix in female and prostate in male.The limitation of this study is that there were many missing medical records as they were not stored in electronic form. Future 
efforts must focus on analyzing the significance between bladder cancer and smoking as its main risk factor in West Java. The high number of bladder cancer cases in male in their 50’s indicates a need for screening for bladder cancer to ensure better care and less mortality rate.
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